Viewing StudyNCT00482495



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00482495
Status: COMPLETED
Last Update Posted: 2011-05-11
First Post: 2007-06-04

Brief Title: Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
stage III multiple myeloma View
refractory multiple myeloma View
stage I multiple myeloma View
stage II multiple myeloma View